Concepedia

Tony D. Angell

TD

3

Publications

154

Citations

3

H-Index

2007

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Tony D. Angell is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2007–2008

3

Publications

3

Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors

J. Hamblin, Tony D. Angell, Stuart P. Ballantine et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 71 citations · Full text

, , +6

Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes

Richard Angell, Tony D. Angell, Paul Bamborough et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 56 citations · Full text

, , +12

Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR

Richard Angell, Tony D. Angell, Paul Bamborough et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 27 citations · Full text

, , +6

Rows per page

1–3 of 3